Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for nursing professionals, 1.25 contact hours (.1 CEUs) for pharmacists, or 1.25 AAPA Category 1 CME credits The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options …
Category Archives: Expired
IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research
Release Date: August 1, 2021 Valid for Credit Through: August 1, 2022 Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research Tracy E. Herring, PhD; Lindsey M. Knowles, PhD; Kevin N. Alschuler, PhD Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, rehabilitation professionals, …
Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now
Release Date: June 29, 2021 Expiration Date: June 29, 2022 Activity Overview This Clinical Consultations™ is a video-based program in which two experts discuss the management of patients with multiple sclerosis (MS) and SARS-CoV-2 vaccinations. In this activity, the faculty focus on the effects of disease modifying therapies (DMTs) on vaccine practices, specifically the mRNA …
IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis
This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in MS, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC). The panelists met in two virtual consensus conferences held on September 3, 2020 and October 16, 2020 to comprehensively review available data, determine practical applications …
Continue reading “IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis”
ECHO MS
Description ECHO MS implements the evidence-based hub and spoke ECHO model™ to create a dynamic learning community between MS expert hub teams and community based MS healthcare providers. The National MS Society operates three hub teams in three time zones: Eastern, Central and Pacific. The hub teams facilitate 12 interactive video conference sessions over a …
Clients with MS: Do No Harm
July 17, 2021 (Virtual) 12:00pm – 3:00pm (ET); 9:00am – 12:00pm (PT) Continuing Education Credit Available for Psychologists and Social Workers. Target Audience This activity has been designed to meet the educational needs of psychologists, social workers, and other members of the healthcare team involved in the management of patients with MS. Learning Objectives Upon …
IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking
Release Date: June1, 2021 Valid for Credit Through: June 1, 2022 Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking Evan T. Cohen, PhD; Sara Huser, DO; Kathleen Barone, BSN; Donald A. Barone, DO Target Audience: The target audience for this activity …
Expert Insights on COVID-19 Vaccinations and High-Efficacy Therapies for Multiple Sclerosis
IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis
Release Date: April1, 2021 Valid for Credit Through: April 1, 2022 Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis Sarah El-Wahsh, BAppSc (Sp Path) (Hons 1); Rob Heard, PhD; Hans Bogaardt, PhD; Fiona Kumfor, PhD; Kirrie J. Ballard, PhD Target Audience: The target audience for this activity is physicians, physician assistants, …
Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis
Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …
Continue reading “Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis”